2-Year Follow-Up of Baroreflex Activation Therapy for Severe Heart Failure With Reduced Ejection Fraction

Figures

• 

  Visual Summary. Basal Characteristics and Results of Patient 1 and Patient 2, After Baroreflex Activation Therapy Implantation ARNI = angiotensin receptor neprilysin inhibitor; GLS = global longitudinal strain; HF = heart failure; HFrEF = heart failure with reduced ejection fraction; HR = heart rate; ICD = implantable cardioverter-defibrillator; iSGLT2 = SGLT2 inhibitor; LA = left atrial; LBBB = left bundle branch block; LVEDVi = left ventricular end-diastolic volume (indexed); LVEF = left ventricular ejection fraction; mA = milliamperes; MRA = mineralocorticoid receptor antagonist; ms = milliseconds; NICM = nonischemic cardiomyopathy; NYHA = New York Heart Association; pps = pulses per second; μs = microseconds.

• 

  Figure 1. X-rays of Patient 1 and Patient 2 After Baroreflex Activation Therapy Implantation (Left) Chest and neck radiograph of patient 1 after implantation of the baroreflex activation therapy system. The pulse generator is implanted on the right pectoral region with an extravascular lead connected to the right carotid sinus. (Right) Chest radiograph of patient 2 after implantation of the baroreflex activation therapy system. The pulse generator is implanted on the right pectoral region. An implantable cardioverter-defibrillator is implanted on the left pectoral region in both cases. R = right.